Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL2889 Target Snapshot

Tyrosine-protein phosphatase non-receptor type 22 · SINGLE PROTEIN · Homo sapiens

704Compounds
123Assays
0Approved Drugs
1,116.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-13

Protein identity stays anchored to UniProt Q9Y2R2. Use UniProt Q9Y2R2 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt Q9Y2R2 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-13
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Tyrosine-protein phosphatase non-receptor type 22 as ChEMBL target CHEMBL2889, mapped to UniProt Q9Y2R2. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Tyrosine-protein phosphatase non-receptor type 22
SINGLE PROTEIN · Homo sapiens
As of 2026-09-13
ChEMBL target ID
CHEMBL2889
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
UniProt accession
Q9Y2R2
Tyrosine-protein phosphatase non-receptor type 22
UniProt accession via ChEMBL component mapping As of 2026-09-13
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Tyrosine-protein phosphatase non-receptor type 22 is the right protein anchor across sources, using UniProt Q9Y2R2 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelTyrosine-protein phosphatase non-receptor type 22
UniProt AccessionQ9Y2R2
Component TypeProtein
Sequence Length807 aa

Tyrosine-protein phosphatase non-receptor type 22

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Tyrosine-protein phosphatase non-receptor type 22, mapped to UniProt Q9Y2R2. Sequence length is 807 aa.

Mapped IDQ9Y2R2
Review nameTyrosine-protein phosphatase non-receptor type 22
OrganismHomo sapiens
Assay Mix

Activity Type Distribution

IC501,074.0
KI41.0
EC501.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL2396719 6.96 Ki 110.0 Preclinical
CHEMBL1701224 6.95 IC50 113.0 Preclinical
CHEMBL2396718 6.77 IC50 171.0 Preclinical
CHEMBL2396719 6.6 IC50 250.0 Preclinical
CHEMBL2396723 6.59 IC50 259.0 Preclinical
CHEMBL2396720 6.58 IC50 263.0 Preclinical
CHEMBL1650888 6.57 IC50 270.0 Preclinical
CHEMBL2396717 6.52 IC50 300.0 Preclinical
CHEMBL2396721 6.51 IC50 310.0 Preclinical
CHEMBL1650889 6.47 IC50 340.0 Preclinical
Distribution

pChEMBL Value Distribution

172
5.0
72
5.5
40
6.0
14
6.5
0
7.0
0
7.5
0
8.0
0
8.5
0
9.0
0
9.5
pChEMBL
Assay Landscape

Assay Landscape

123
Total Assays
247
Tested Compounds
3
Assay Types
Binding — 108 assays, 247 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 41 26 5.2
single protein format 37 119 5.3
assay format 30 102 5.2
Functional — 10 assays, 84 compounds
BAO Format Assays Compounds Avg pChEMBL
assay format 10 84 5.0
ADME — 5 assays, 1 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 4 1 5.3
assay format 1 0

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine